The present invention provides a pharmaceutical composition for oral administration, comprising (a) 4 to 40 % by weight of a taxane, (b) 10 to 30 % by weight of a medium chain triglyceride, (c) 30 to 70 % by weight of monooleoyl glycerol, (d) 5 to 30 % by weight of a surfactant, and (e) 10 to 30 % by weight of polyoxyl glyceryl fatty acid ester and a process for preparing the same.